Replimune Group, Inc.
Industry: Life Sciences ・ $REPL on Nasdaq
Insider Sale
+$119,108
-11.94%
Shares
Shares Volume: 15,881 Shares
Average Share Price: $7.5
INSIDER
Xynos Konstantinos
Chief Medical Officer (Officer)
reported on Jun 10 2024
traded on Jun 7 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 117,131 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $80,053.32 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $142,067.49 |
| COMPANY PREVIOUS TRADES |